Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Disease to Bone”

512 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 512 results

Not applicableEnded earlyNCT00981578
What this trial is testing

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone Metastases
InSightec 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT01885689
What this trial is testing

Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in Remission+4 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02125318
What this trial is testing

Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Who this might be right for
ThrombocytosisMyeloproliferative Neoplasms
Galena Biopharma, Inc. 18
Not applicableStudy completedNCT00392938
What this trial is testing

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

Who this might be right for
Metastatic CancerProstate Cancer
University of Washington 11
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Large-scale testing (Phase 3)Study completedNCT04812509
What this trial is testing

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Mabwell (Shanghai) Bioscience Co., Ltd. 708
Testing effectiveness (Phase 2)Ended earlyNCT00001880
What this trial is testing

Stem Cell Transplantation for Metastatic Solid Tumors

Who this might be right for
Neoplasm Metastasis
National Heart, Lung, and Blood Institute (NHLBI) 42
Post-approval studies (Phase 4)Study completedNCT01633853
What this trial is testing

Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder

Who this might be right for
Vitamin D Deficiency
Dongliang Zhang, MD 204
Post-approval studies (Phase 4)Ended earlyNCT00381095
What this trial is testing

Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer

Who this might be right for
Bone NeoplasmsPain, IntractableCancer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 152
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT03833661
What this trial is testing

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 159
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Large-scale testing (Phase 3)Study completedNCT04750460
What this trial is testing

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease-Mineral and Bone DisorderDialysis+2 more
Saint Petersburg State University, Russia 20
Testing effectiveness (Phase 2)Study completedNCT00503295
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Who this might be right for
OsteosarcomaEwing Sarcoma Family TumorsMalignant Fibrous Histiocytoma+3 more
Oncolytics Biotech 53
Testing effectiveness (Phase 2)Study completedNCT05280067
What this trial is testing

ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES

Who this might be right for
Metastatic Breast Cancer in the Spine
Zetagen Therapeutics, Inc 10
Testing effectiveness (Phase 2)Study completedNCT00739388
What this trial is testing

Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy

Who this might be right for
Leukemia
Swiss Cancer Institute 47
Early research (Phase 1)WithdrawnNCT04896112
What this trial is testing

LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaPrimary MyelofibrosisPost-polycythemia Vera Myelofibrosis+2 more
Lynk Pharmaceuticals Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15
Next Page
72